EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMixed-Methods-StudieOpen Access · CC BY 4.0

Patient Preferences and Cosmetic Outcomes Following Destructive Treatments for Non-facial Basal Cell Carcinoma: A Mixed Methods Study

Eva Backman iD, Birgit Heckemann iD, Martin Gillstedt iD, Sam Polesie iD, John Paoli iD

Acta Dermato-Venereologica · 2025

DOI: 10.2340/actadv.v105.41325 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Acta Dermato-Venereologica, 2025. Verfasst von Eva Backman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden; Region Västra Götal…. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Cicatrix, Patient Preference, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high prevalence of basal cell carcinoma (BCC) entails a substantial burden on healthcare systems. Interest in non-surgical treatment methods for low-risk BCCs, including destructive treatments, is increasing. Dermatologists often highlight suboptimal cosmetic outcomes as drawbacks of destructive treatments, also for non-facial lesions. Patient perspectives regarding scarring and cosmetic outcomes in relation to other relevant factors are largely unknown, yet important to consider in shared decision-making when choosing treatment. This study investigates patient perceptions of scarring following destructive treatments and explores important factors in treatment decisions for non-facial BCCs. Through a mixed-methods design, cosmetic outcomes, patient satisfaction, scarring concerns, and treatment preferences were evaluated within an ongoing randomized clinical trial on destructive treatments for low-risk BCCs. Overall, 157 patients with 425 non-facial scars were assessed. Most patients were not concerned about scar appearance, highlighting a discrepancy compared with dermatologists’ general concerns regarding inferior cosmetic outcome. Instead, when opting for specific treatments, patients listed clearance rates as the most important factor, followed by convenience and time consumption. We believe the results are important both in the context of patient-centred care and in “choosing wisely” when deciding between BCC treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell CarcinomaCicatrixPatient PreferenceSkin NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedEstheticsPatient SatisfactionTreatment OutcomeFollow-Up Studies

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Dermatology and Ve…
  • Institute of Health and Care Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Anesthesiology and Intensive Care Medicine/ Pain Centr…

ORCID-Profile: Eva Backman, Birgit Heckemann, Martin Gillstedt, Sam Polesie, John Paoli

Zitieren

APA

Backman, E., Heckemann, B., Gillstedt, M., Polesie, S., & Paoli, J. (2025). Patient Preferences and Cosmetic Outcomes Following Destructive Treatments for Non-facial Basal Cell Carcinoma: A Mixed Methods Study. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v105.41325

Vancouver

Backman E, Heckemann B, Gillstedt M, Polesie S, Paoli J. Patient Preferences and Cosmetic Outcomes Following Destructive Treatments for Non-facial Basal Cell Carcinoma: A Mixed Methods Study. Acta Dermato-Venereologica. 2025. doi:10.2340/actadv.v105.41325

BibTeX
@article{Backman2025,
  author = {Backman, Eva and Heckemann, Birgit and Gillstedt, Martin and Polesie, Sam and Paoli, John},
  title = {Patient Preferences and Cosmetic Outcomes Following Destructive Treatments for Non-facial Basal Cell Carcinoma: A Mixed Methods Study},
  journal = {Acta Dermato-Venereologica},
  year = {2025},
  doi = {10.2340/actadv.v105.41325}
}
Kostenlos starten →